drugset / Trial / NCT02288286
Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans
Phase 3
Completed
1200 enrolled
Beijing Center for Disease Control and Prevention
Beijing Minhai Biotechnology Co., Ltd · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of freeze-dried rabies vaccine (MRC-5 cells)in different age health human populations, according to the traditional Essen methods (1-1-1-1-1) vaccination.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-02
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabies Vaccine（MRC-5 Cell) | Vaccine | 2.5 unknown | — |
| Comparator | Rabies Vaccine（vero Cell) | Vaccine | 2.5 unknown | — |
Indications
No indication recorded.